Request for Comments and Announcement of Public Workshop Follow-On Biologics: Impact of Recent Legislative and Regulatory Naming Proposals on Competition #00037

Submission Number:
00037
Commenter:
Mark McCamish
Organization:
Novartis (Sandoz)
State:
New Jersey
Initiative Name:
Request for Comments and Announcement of Public Workshop Follow-On Biologics: Impact of Recent Legislative and Regulatory Naming Proposals on Competition
Matter Number:

Request for Comments and Announcement of Public Workshop Follow-On Biologics: Impact of Recent Legislative and Regulatory Naming Proposals on Competition

Please see attached letter and 2 of 20 references. Due to the limit of 3 attachments,the other 18 references will be provided to FTC by alternate means.